【24h】

Cell cycle kinases in cancer

机译:癌症中的细胞周期激酶

获取原文
获取原文并翻译 | 示例
           

摘要

Cell division in mammalian cells is driven by protein kinases that regulate progression through the various phases of the cell cycle. Cyclin-dependent kinases (Cdks) regulate cell cycle commitment, DNA synthesis and the onset of mitosis. Kinases of the Aurora, Polo and Nek families participate in the centrosome cycle and modulate spindle function. Additional kinases such as Bub1, BubR1 and Mps1 regulate the spindle assembly checkpoint. It has been well established that misregulation of Cdks is one of the most frequent alterations in human cancer. Recent evidence indicates that mutations involving mitotic kinases are also linked to tumor development. These findings suggest novel strategies to use cell cycle kinases as targets for therapeutic intervention.
机译:哺乳动物细胞中的细胞分裂是由调节整个细胞周期各个阶段进程的蛋白激酶驱动的。细胞周期蛋白依赖性激酶(Cdks)调节细胞周期承诺,DNA合成和有丝分裂的发作。 Aurora,Polo和Nek家族的激酶参与中心体周期并调节纺锤体功能。其他激酶(例如Bub1,BubR1和Mps1)调节主轴组装检查点。众所周知,Cdks的失调是人类癌症中最常见的改变之一。最近的证据表明,涉及有丝分裂激酶的突变也与肿瘤的发展有关。这些发现表明使用细胞周期激酶作为治疗干预目标的新策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号